The expression of AML1-ETO9a isoform in acute myeloid leukemia M2 subtype and its clinical significance.

被引：0
|
作者：
Miao, Yu Q.
Chen, Zi X.
Cen, Jian N.
Yan, Ming
He, Jun
Qiu, Qiao Ch.
Zhang, Dong E.
机构：
[1] Soochow Univ, 1 Affiliated Hosp, Jiainsngsu Inst Hematol, Leukemia Unit, Suzhou, Peoples R China
[2] Scripps Res Inst, Dept Mol & Expt Med, Div Oncovirol, La Jolla, CA USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2317
引用
收藏
页码：656A / 656A
页数：1
相关论文
共 50 条
  • [1] The coexpression of AML1-ETO9a isoform and AML1-ETO in acute myeloid leukemia M2 subtype and its clinical significance
    Zhang, Hong
    Chen, Zi-xing
    He, Jun
    Miao, Yu-qin
    Cen, Jian-nong
    Qiu, Qiao-chen
    BLOOD, 2007, 110 (11) : 706A - 706A
  • [2] Anticardiolipin antibodies in acute myeloid leukemia (AML): Prevalence and clinical significance.
    Lossos, IS
    Matzner, Y
    BLOOD, 1997, 90 (10) : 3713 - 3713
  • [3] Functional and clinical characterization of the alternatively spliced isoform AML1-ETO9a in adult patients with translocation t(8;21)(q22;q22.1) acute myeloid leukemia (AML)
    Mridul Agrawal
    Peggy Schwarz
    Benedetto Daniele Giaimo
    Ivan Bedzhov
    Andrea Corbacioglu
    Daniela Weber
    Verena I. Gaidzik
    Nikolaus Jahn
    Frank G. Rücker
    Thomas Schroeder
    Thomas Kindler
    Mohammed Wattad
    Katharina Götze
    Michael Lübbert
    Hans Salwender
    Mark Ringhoffer
    Elisabeth Lange
    Elisabeth Koller
    Felicitas Thol
    Michael Heuser
    Arnold Ganser
    Lars Bullinger
    Peter Paschka
    Hartmut Döhner
    Hartmut Geiger
    Tilman Borggrefe
    Konstanze Döhner
    Franz Oswald
    Leukemia, 2020, 34 : 630 - 634
  • [4] Functional and clinical characterization of the alternatively spliced isoform AML1-ETO9a in adult patients with translocation t(8;21)(q22; q22.1) acute myeloid leukemia (AML)
    Agrawal, Mridul
    Schwarz, Peggy
    Giaimo, Benedetto Daniele
    Bedzhov, Ivan
    Corbacioglu, Andrea
    Weber, Daniela
    Gaidzik, Verena I.
    Jahn, Nikolaus
    Ruecker, Frank G.
    Schroeder, Thomas
    Kindler, Thomas
    Wattad, Mohammed
    Goetze, Katharina
    Luebbert, Michael
    Salwender, Hans
    Ringhoffer, Mark
    Lange, Elisabeth
    Koller, Elisabeth
    Thol, Felicitas
    Heuser, Michael
    Ganser, Arnold
    Bullinger, Lars
    Paschka, Peter
    Doehner, Hartmut
    Geiger, Hartmut
    Borggrefe, Tilman
    Doehner, Konstanze
    Oswald, Franz
    LEUKEMIA, 2020, 34 (02) : 630 - 634
  • [5] AML1-ETO9a is correlated with C-KIT overexpression/mutations and indicates poor disease outcome in t(8;21) acute myeloid leukemia-M2
    Jiao, B.
    Wu, C-F
    Liang, Y.
    Chen, H-M
    Xiong, S-M
    Chen, B.
    Shi, J-Y
    Wang, Y-Y
    Wang, J-H
    Chen, Y.
    Li, J-M
    Gu, L-J
    Tang, J-Y
    Shen, Z-X
    Gu, B-W
    Zhao, W-L
    Chen, Z.
    Chen, S-J
    LEUKEMIA, 2009, 23 (09) : 1598 - 1604
  • [6] AML1-ETO9a is correlated with C-KIT overexpression/mutations and indicates poor disease outcome in t(8;21) acute myeloid leukemia-M2
    B Jiao
    C-F Wu
    Y Liang
    H-M Chen
    S-M Xiong
    B Chen
    J-Y Shi
    Y-Y Wang
    J-H Wang
    Y Chen
    J-M Li
    L-J Gu
    J-Y Tang
    Z-X Shen
    B-W Gu
    W-L Zhao
    Z Chen
    S-J Chen
    Leukemia, 2009, 23 : 1598 - 1604
  • [7] Clinical Relevance of Alternatively Spliced Isoform AML1-ETO9a in Adult Patients with t(8;21)(q22; q22.1) Acute Myeloid Leukemia (AML): A Study of the German-Austrian AML Study Group (AMLSG)
    Agrawal, Mridul
    Corbacioglu, Andrea
    Weber, Daniela
    Gaidzik, Verena I.
    Habdank, Marianne
    Jahn, Nikolaus
    Schroeder, Thomas Michael
    Kindler, Thomas
    Wattad, Mohammed Amen
    Lubbert, Michael
    Fiedler, Walter
    Gotze, Katharina S.
    Ringhoffer, Mark
    Schleicher, Jan
    Lange, Elisabeth
    Pfreundschuh, Michael
    Griesshammer, Martin
    Greil, Richard
    Kirchen, Heinz
    Koller, Elisabeth
    Thol, Felicitas
    Krauter, Jurgen
    Schlenk, Richard F.
    Heuser, Michael
    Ganser, Arnold
    Bullinger, Lars
    Paschka, Peter
    Dohner, Hartmut
    Dohner, Konstanze
    BLOOD, 2017, 130
  • [8] Amyloid precursor protein has clinical and prognostic significance in AML1-ETO-positive acute myeloid leukemia
    Yu, Guopan
    Yin, Changxin
    Jiang, Ling
    Xu, Dan
    Zheng, Zhongxin
    Wang, Zhixiang
    Wang, Chunli
    Zhou, Hongsheng
    Jiang, Xuejie
    Liu, Qifa
    Meng, Fanyi
    ONCOLOGY LETTERS, 2018, 15 (01) : 917 - 925
  • [9] AML1-ETO9a correlated with C-KIT overexpression/mutation and indicated poor disease outcome in t(8;21) acute myeloid leukemia
    Liang, Yang
    Jiao, Bo
    Wu, Chuan-Feng
    Xiong, Shu-Min
    Gu, Long-Jun
    Chen, Zhu
    Chen, Sai-Juan
    BLOOD, 2007, 110 (11) : 540A - 540A
  • [10] The combined expression of AML1-ETO and oncogenic RAS is insufficient to induce acute myeloid leukemia (AML).
    Flotho, C
    Sun, WL
    Shurtleff, S
    Yang, SL
    Downing, JR
    BLOOD, 2004, 104 (11) : 700A - 700A
12345